How should a patient with rheumatoid arthritis behave after achievement of remission?

The paper considers the very urgent problem of optimization of the management of rheumatoid arthritis (RA) patients who have achieved remission (or persistent low disease activity) during therapy using biologicals. It analyzes the results of BeSt, OPTIMA, HIT HARD, ACT-RAY, AVERT, PRESERVE, RETRO, P...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteur: D. E. Karateev
Formaat: Artigo
Taal:Russo
Gepubliceerd in: IMA-PRESS LLC 2016-03-01
Reeks:Современная ревматология
Onderwerpen:
remission
biologicals
rheumatoid arthritis
psoriasis
dose reduction
therapy discontinuation
tumor necrosis factor-α inhibitors
etanercept
abatacept
adalimumab
tocilizumab
infliximab
Online toegang:https://mrj.ima-press.net/mrj/article/view/670
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items